| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 1945 |
| 1 | PREDNISOLONE | 1781 |
| 2 | PREDNISOLONE ORAL | 1781 |
| 3 | PREDNISOLONE ORAL SOLUTION | 1781 |
| 4 | METHOTREXATE SODIUM | 1554 |
| 5 | RITUXIMAB | 1428 |
| 6 | METHOTREXATE | 1366 |
| 7 | TACROLIMUS | 1298 |
| 8 | MYCOPHENOLATE MOFETIL | 1271 |
| 9 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1271 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ATOVAQUONE | 155 | 0.0188 |
| 1 | BELATACEPT | 87 | 0.0184 |
| 2 | GANCICLOVIR SODIUM | 166 | 0.0155 |
| 3 | VANCOMYCIN HYDROCHLORIDE | 117 | 0.0140 |
| 4 | BRENTUXIMAB VEDOTIN | 142 | 0.0137 |
| 5 | BASILIXIMAB | 138 | 0.0116 |
| 6 | DACARBAZINE | 86 | 0.0114 |
| 7 | VALGANCICLOVIR | 207 | 0.0108 |
| 8 | PREDNISOLONE ORAL SOLUTION | 1781 | 0.0097 |
| 9 | GOLIMUMAB | 119 | 0.0094 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 5104 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 1525 |
| 2 | Alkylating Drug [EPC] | 1472 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 1428 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 813 |
| 5 | Kinase Inhibitor [EPC] | 758 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 520 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 492 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 474 |
| 9 | Purine Antimetabolite [EPC] | 449 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adrenal Steroid Synthesis Inhibitor [EPC] | 35 | 0.0350 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 154 | 0.0263 |
| 2 | Selective T Cell Costimulation Blocker [EPC] | 87 | 0.0184 |
| 3 | Antimalarial [EPC] | 155 | 0.0148 |
| 4 | Antiprotozoal [EPC] | 156 | 0.0147 |
| 5 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 316 | 0.0142 |
| 6 | CD30-directed Immunoconjugate [EPC] | 142 | 0.0137 |
| 7 | CD19-directed Cytolytic Antibody [EPC] | 9 | 0.0105 |
| 8 | Interleukin-5 Antagonist [EPC] | 6 | 0.0087 |
| 9 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 11 | 0.0087 |